Teva Profit Outlook Edges Up With Cost-Cutting Plan on Track
A logo is displayed on employees white factory overalls hanging on a rail at Teva Pharmaceutical Industries Ltd.’s factory. (Photographer: Akos Stiller/Bloomberg)

Teva Profit Outlook Edges Up With Cost-Cutting Plan on Track

(Bloomberg) -- Teva Pharmaceutical Industries Ltd. raised the bottom end of its earnings and sales forecasts as Chief Executive Officer Kare Schultz’s cost-cutting plan remained on target.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.